Floy AI Radiology Platform - Opportunistic Screening

Healthcare generates 30% of the world's data, yet 97% of it remains unused. Floy's certified AI software analyzes every radiological scan beyond its original indication, uncovering clinically relevant findings that might otherwise go unnoticed. By turning routine imaging into a tool for opportunistic risk detection, Floy empowers radiologists to make faster, broader, and more informed decisions.

The demand for radiological imaging is increasing by 10% annually, while the number of radiologists grows by only 4%. In a time-pressured environment where medical professionals have only seconds to scan images for potential anomalies, approximately 25% of diagnoses are incorrect and many early signs of disease remain undetected. This is especially true for rare conditions that are easily overlooked.

Floy reveals insights that extend beyond the primary indication of every scan:

• Bone Health - Detect osteoporosis at an early stage through automated bone density analysis
• Vascular Status - Assess cardiovascular risk factors from routine imaging
• Incidental Findings - Identify risk factors that would otherwise go unnoticed
• Pulmonary Nodules - Detect, classify, and measure potentially malignant lung lesions including comparison with prior scans
• Bone Lesions - Identify and classify potentially malignant spinal lesions in MRI and CT

Research indicates that radiologists utilizing Floy's AI have achieved a 34% increase in detection sensitivity of pulmonary nodules and a 42% decrease in false-positive rates.

Floy supports radiologists in routine diagnostics with precision and objectivity:

• Brain Volumetry - Precisely and fully automatically measures brain region volumes in MRI, comparing them with age- and sex-specific normative cohorts for early diagnosis of neurodegenerative diseases
• Multiple Sclerosis - Fully automatically detects and measures MS lesions in brain MRI, including comparison with prior scans
• Abdominal Volumetry - Measures the volume of organs, abdominal wall muscles, and subcutaneous and visceral fat in abdominal MRI and CT scans
• Organ Measurement - Millimeter-accurate automated measurements for standardized risk assessment
• Tumor Detection - Evaluate progression over time with automated comparison to prior imaging

Floy's medical AI devices have achieved European MDR Certification, validating compliance with strict medical software regulations. The AI models are trained on 17 million medical examinations and validated by 18 in-house radiologists to ensure real clinical value. Floy cooperates with research institutions such as the German Cancer Research Centre (DKFZ) to continuously improve AI quality.

Over 250 radiology sites across Germany and Europe rely on Floy every day. The platform integrates seamlessly into existing radiology workflows and serves as a diagnostic assistant - radiologists remain in charge of all diagnoses while gaining enhanced detection capabilities and structured additional information.

The FloyReport provides a clear, consolidated view of all AI-detected findings, delivering structured results that complement the radiologist's standard report. Specialized modules include FloyBrain, FloySpine, and FloyMammo for targeted analysis across different anatomical regions.

Founded in 2021 and based in Munich, Floy has secured more than 12 million euros in funding. The company brings together leading minds in technology, medicine, and science with one clear mission: Maximize. Human. Health.